Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fantini

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Gastroenterologie Clinique Et Biologique|December 1, 1985
[The intestinal immune system. The VIP receptor on T lymphocytes: a new marker of differentiation?]J Fantini, A Tirard, A el Battari, et al.
European Journal of Biochemistry|September 1, 1987
Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptorsJ Luis, J M Martin, A el Battari, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|September 1, 1987
Growth in serum-free medium of human colonic adenocarcinoma cell lines on microcarriers: a two-step method allowing optimal cell spreading and growthJ Fantini, J P Galons, B Abadie, et al.
Journal of Cell Science|July 1, 1986
Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29J Fantini, B Abadie, A Tirard, et al.
The Journal of Biological Chemistry|March 14, 1997
Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entryJ Fantini, D Hammache, O Delézay, et al.
Journal of Medicinal Chemistry|June 19, 2001
Amphiphilic anionic analogues of galactosylceramide: synthesis, anti-HIV-1 activity, and gp120 bindingB Faroux-Corlay, J Greiner, R Terreux, et al.
The Biochemical Journal|February 15, 1987
The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein natureA el Battari, J Luis, J M Martin, et al.
Cell Death and Differentiation|August 2, 2008
The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligandK Chakrabandhu, S Huault, N Garmy, et al.
The American Journal of Pathology|November 7, 2001
Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathyF Clayton, D P Kotler, S K Kuwada, et al.
Virology|May 4, 2000
Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutationsC Tamalet, N Yahi, C Tourrès, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Gastroenterologie Clinique Et Biologique|December 1, 1985
[The intestinal immune system. The VIP receptor on T lymphocytes: a new marker of differentiation?]J Fantini, A Tirard, A el Battari, et al.
European Journal of Biochemistry|September 1, 1987
Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptorsJ Luis, J M Martin, A el Battari, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|September 1, 1987
Growth in serum-free medium of human colonic adenocarcinoma cell lines on microcarriers: a two-step method allowing optimal cell spreading and growthJ Fantini, J P Galons, B Abadie, et al.
Journal of Cell Science|July 1, 1986
Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29J Fantini, B Abadie, A Tirard, et al.
The Journal of Biological Chemistry|March 14, 1997
Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entryJ Fantini, D Hammache, O Delézay, et al.
Journal of Medicinal Chemistry|June 19, 2001
Amphiphilic anionic analogues of galactosylceramide: synthesis, anti-HIV-1 activity, and gp120 bindingB Faroux-Corlay, J Greiner, R Terreux, et al.
The Biochemical Journal|February 15, 1987
The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein natureA el Battari, J Luis, J M Martin, et al.
Cell Death and Differentiation|August 2, 2008
The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligandK Chakrabandhu, S Huault, N Garmy, et al.
The American Journal of Pathology|November 7, 2001
Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathyF Clayton, D P Kotler, S K Kuwada, et al.
Virology|May 4, 2000
Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutationsC Tamalet, N Yahi, C Tourrès, et al.
Pageof 11